GI Oncology
Conference Coverage
Pancreatic cancer screening appears safe, effective for high-risk patients
The study explored a targeted strategy for screening since pancreatic cancer screening is not recommended for the general population.
Conference Coverage
First RCT evaluating benefits of colonoscopy screening rocks GI: NordICC
In an intention-to-screen analysis, 10-year results from the NordICC trial show that colonoscopy reduces the risk of colorectal cancer by only 18...
Conference Coverage
One-third of pancreatic cancer diagnoses missed on scans
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
From the AGA Journals
Looking for the source of neuroendocrine tumors
The research could eventually lead to identification of unique cells-of-origin for these tumors – as well as potential treatment targets.
From the Journals
Will AI affect the burden of patient surveillance after polyp removal?
AI-assisted colonoscopy may increase the proportion of patients requiring intensive postpolypectomy colonoscopy surveillance by roughly 35% in the...
From the Journals
AI tool may improve prediction of colorectal cancer recurrence
The QuantCRC algorithm can identify subsets of patients with colorectal cancer who may not need chemotherapy and who may need more intensive...
From the Journals
Risk-adapted screening strategy could reduce colonoscopy use
In countries with limited health care resources, risk-adapted screening strategies could be more cost effective and accessible.
From the Journals
Pandemic-related CRC screening delays affect older adults most
Since previously unscreened 65-year-olds lose the most benefit from delayed colorectal cancer screenings, they should be prioritized when access...
From the AGA Journals
Inhibiting adenosine pathways may be key to CRC treatment
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.
From the Journals
After index colonoscopy, what’s the CRC risk in 40- to 49-year-olds vs. 50- to 59-year-olds?
Advanced neoplasia risk is lower in younger patients when no adenoma is detected on index colonoscopy, new research indicates.